| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113883.3.526.3.1139 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.526.3.1139/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1139 |
| Version | 20210218 |
| Status | active |
| Date | 2021-02-18T01:00:59-05:00 |
| Name | ACEInhibitorOrARBOrARNI |
| Title | ACE Inhibitor or ARB or ARNI |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications of angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor-neprilysin inhibitor (ARNI) therapies.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor-neprilysin inhibitor (ARNI) therapies.s diuretic, ACEI plus calcium channel blocker, ARB plus calcium channel blocker, or ARB plus calcium channel blocker plus diuretic.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR